Showing results (2691-2700 of 6,794) with videos related to

Sort By:
Pageof 680
Clinical Therapeutics|October 29, 2017
Management of Allergic Rhinitis: A Review for the Community PharmacistJ Russell May, William K Dolen
Clinical Therapeutics|October 29, 2017
Examining and Enabling the Role of Health Care Providers as Patient Engagement Facilitators in Clinical TrialsKenneth A Getz
Clinical Therapeutics|November 28, 2017
Pharmacokinetics of a New Amphetamine Extended-release Oral Liquid Suspension Under Fasted and Fed Conditions in Healthy Adults: A Randomized, Open-label, Single-dose, 3-treatment StudyCarolyn Sikes, Jeffrey G Stark, Russ McMahen, et al.
Clinical Therapeutics|November 28, 2017
Management of Well-differentiated Gastroenteropancreatic Neuroendocrine Tumors (GEPNETs): A ReviewGurleen Pasricha, Parikshit Padhi, Nour Daboul, et al.
Clinical Therapeutics|December 5, 2017
Effects of Exercise on Non-motor Symptoms in Parkinson's DiseaseAmy W Amara, Adeel A Memon
Clinical Therapeutics|November 4, 2017
Improving Patient Involvement in the Drug Development Process: Case Study of Potential Applications from an Online Peer Support NetworkAmrutha Anand, Helen Jane Brandwood, Matt Jameson Evans
Clinical Therapeutics|December 18, 2017
Efficacy and Tolerability of Telmisartan/Amlodipine + Hydrochlorothiazide Versus Telmisartan/Amlodipine Combination Therapy for Essential Hypertension Uncontrolled With Telmisartan/Amlodipine: The Phase III, Multicenter, Randomized, Double-blind TAHYTI StudyKi-Chul Sung, Yong-Seog Oh, Dong-Hun Cha, et al.
Clinical Therapeutics|September 19, 2017
Treatment Patterns, Health Care Resource Utilization, and Spending in Medicaid Beneficiaries Initiating Second-generation Long-acting Injectable Agents Versus Oral Atypical AntipsychoticsDominic Pilon, Neeta Tandon, Marie-Hélène Lafeuille, et al.
Clinical Therapeutics|September 20, 2017
Use of Adult Sensory Panel to Study Individual Differences in the Palatability of a Pediatric HIV Treatment DrugJulie A Mennella, Phoebe S Mathew, Elizabeth D Lowenthal
Clinical Therapeutics|September 20, 2017
Use of Prohibited Medication, a Potentially Overlooked Confounder in Clinical Trials: Omarigliptin (Once-weekly DPP-4 Inhibitor) Monotherapy Trial in 18- to 45-year-oldsIra Gantz, Liubov Sokolova, Lokesh Jain, et al.
Pageof 680